[1] |
Zhou Q, Wang H, Schwartz DM, et al. Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease[J]. Nat Genet, 2016, 48(1): 67-73.
doi: 10.1038/ng.3459
|
[2] |
Catrysse L, Vereecke L, Beyaert R, et al. A20 in inflammation and autoimmunity[J]. Trends Immunol, 2014, 35(1): 22-31.
doi: 10.1016/j.it.2013.10.005
pmid: 24246475
|
[3] |
Aeschlimann FA, Laxer RM. Haploinsufficiency of A20 and other paediatric inflammatory disorders with mucosal involvement[J]. Curr Opin Rheumatol, 2018, 30(5): 506-513.
doi: 10.1097/BOR.0000000000000532
pmid: 29916847
|
[4] |
Aeschlimann FA, Batu ED, Canna SW, et al. A20 haploinsufficiency (HA20): clinical phenotypes and disease course of patients with a newly recognised NF-kB-mediated autoinflammatory disease[J]. Ann Rheum Dis, 2018, 77(5): 728-735.
doi: 10.1136/annrheumdis-2017-212403
pmid: 29317407
|
[5] |
Kadowaki T, Ohnishi H, Kawamoto N, et al. Haploinsufficiency of A20 causes autoinflammatory and autoimmune disorders[J]. J Allergy Clin Immunol, 2018, 141(4): 1485-1488.
doi: S0091-6749(17)31885-7
pmid: 29241730
|
[6] |
Duncan CJA, Dinnigan E, Theobald R, et al. Early-onset autoimmune disease due to a heterozygous loss-of-function mutation in TNFAIP3 (A20)[J]. Ann Rheum Dis, 2018, 77(5): 783-786.
doi: 10.1136/annrheumdis-2016-210944
|
[7] |
Ohnishi H, Kawamoto N, Seishima M, et al. A Japanese family case with juvenile onset Behçet's disease caused by TNFAIP3 mutation[J]. Allergol Int, 2017, 66(1): 146-148.
doi: 10.1016/j.alit.2016.06.006
|
[8] |
Shigemura T, Kaneko N, Kobayashi N, et al. Novel heterozygous C243Y A20/TNFAIP3 gene mutation is responsible for chronic inflammation in autosomal-dominant Behçet's disease[J]. RMD Open, 2016, 2(1): e000223.
doi: 10.1136/rmdopen-2015-000223
|
[9] |
Takagi M, Ogata S, Ueno H, et al. Haploinsufficiency of TNFAIP3 (A20) by germline mutation is involved in autoimmune lymphoproliferative syndrome[J]. J Allergy Clin Immunol, 2017, 139(6): 1914-1922.
doi: 10.1016/j.jaci.2016.09.038
|
[10] |
Franco-Jarava C, Wang H, Martin-Nalda A, et al. TNFAIP3 haploinsufficiency is the cause of autoinflammatory manifestations in a patient with a deletion of 13Mb on chromosome 6[J]. Clin Immunol, 2018, 191: 44-51.
doi: S1521-6616(18)30122-0
pmid: 29572183
|
[11] |
Wertz IE, O'Rourke KM, Zhou H, et al. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling[J]. Nature, 2004, 430(7000): 694-699.
doi: 10.1038/nature02794
|
[12] |
Coornaert B, Carpentier I, Beyaert R. A20: central gatekeeper in inflammation and immunity[J]. J Biol Chem, 2009, 284(13): 8217-8221.
doi: 10.1074/jbc.R800032200
pmid: 19008218
|
[13] |
Gans MD, Wang H, Moura NS, et al. A20 haplo-insufficiency presenting with a combined immunodeficiency[J]. J Clin Immunol, 2020, 40(7): 1041-1044.
doi: 10.1007/s10875-020-00823-5
|
[14] |
Shaheen ZR, Williams SJA, Binstadt BA. Case report: a novel TNFAIP3 mutation causing haploinsufficiency of A20 with a lupus-like phenotype[J]. Front Immunol, 2021, 12: 629457.
doi: 10.3389/fimmu.2021.629457
|
[15] |
Yu MP, Xu XS, Zhou Q, et al. Haploinsufficiency of A20 (HA20): updates on the genetics, phenotype, pathogenesis and treatment[J]. World J Pediatr, 2020, 16(6): 575-584.
doi: 10.1007/s12519-019-00288-6
|
[16] |
Wakatsuki R, Hatai Y, Okamoto K, et al. An infant with A20 haploinsufficiency presenting with periodic fever syndrome: A case report[J]. Int J Rheum Dis, 2023, 26(5): 973-976.
doi: 10.1111/apl.v26.5
|
[17] |
Aslani N, Asnaashari K, Parvaneh N, et al. TNFAIP3 mutation causing haploinsufficiency of A20 with a hemophagocytic lymphohistiocytosis phenotype: a report of two cases[J]. Pediatr Rheumatol Online J, 2022, 20(1): 78.
doi: 10.1186/s12969-022-00735-1
pmid: 36064566
|
[18] |
Jo KJ, Park SE, Cheon CK, et al. Haploinsufficiency A20 misdiagnosed as PFAPA (periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis) syndrome with Kikuchi disease[J]. Clin Exp Pediatr, 2023, 66(2): 82-84.
doi: 10.3345/cep.2022.00500
|
[19] |
He T, Huang Y, Luo Y, et al. Haploinsufficiency of A20 due to novel mutations in TNFAIP3[J]. J Clin Immunol. 2020, 40(5): 741-751.
doi: 10.1007/s10875-020-00792-9
|
[20] |
Gudmundsson S, Singer-Berk M, Watts NA, et al. Variant interpretation using population databases: Lessons from gnomAD[J]. Hum Mutat, 2022, 43(8): 1012-1030.
doi: 10.1002/humu.v43.8
|
[21] |
Mahat U, Ambani NM, Rotz SJ, et al. Heterozygous CTLA4 splice site mutation c.458-1G > C presenting with immunodeficiency and variable degree of immune dysregulation in three generation kindred of Caribbean descent[J]. Pediatr Hematol Oncol. 2021, 38(7): 658-662.
doi: 10.1080/08880018.2021.1906802
|
[22] |
Kingdom R, Wright CF. Incomplete penetrance and variable expressivity: from clinical studies to population cohorts[J]. Front Genet, 2022, 13: 920390.
doi: 10.3389/fgene.2022.920390
|
[23] |
Mitsunaga K, Inoue Y, Naito C, et al. A case of A20 haploinsufficiency in which intestinal inflammation improved with thalidomide[J]. Rheumatology (Oxford), 2023, 62(6): e193-e195.
doi: 10.1093/rheumatology/keac634
|
[24] |
Shiraki M, Williams E, Yokoyama N, et al. Hematopoietic cell transplantation ameliorates autoinflammation in A20 haploinsufficiency[J]. J Clin Immunol, 2021, 41(8): 1954-1956.
doi: 10.1007/s10875-021-01124-1
pmid: 34427832
|